Results 211 to 220 of about 384,866 (306)

Beyond Joints: Neuropsychiatric Benefits of TNF-α and IL-6 Inhibitors in Rheumatoid Arthritis-Narrative Review. [PDF]

Int J Mol Sci
Siuchnińska H, Minarowska A, Wasilewska E.   +2 more
europepmc   +1 more source

Neuropsychiatric Symptoms After HHV-6 Encephalitis in an Immunocompetent Child: A Case Report. [PDF]

Am J Case Rep
Habanjar D, Trad S, Charouf D, Kreidly S, Boustany RM.   +4 more
europepmc   +1 more source

Pharmacology of oxazepam (Serax), a new anti-anxiety agent.

Current therapeutic research, clinical and experimental, 1966
openaire   +1 more source

The immunological mechanisms linking systemic lupus erythematosus and neuropsychiatric disorders. [PDF]

Front Immunol
Su ST, Kuo P, Shih PC, Wei JC.
europepmc   +1 more source

Toward a Critique of Critique: Paradoxes of Byung‐Chul Han and the Dialectic of Despair and Possibility

Constellations, EarlyView.
İbrahim Berkan Karataş
wiley   +1 more source

A pilot investigation of clinical effects of PM-33, a new anti-anxiety agent.

Current therapeutic research, clinical and experimental, 1975
F S, Abuzzahab, A S, Kulkarni
openaire   +1 more source

Refusing to Listen: Receptive Audiences and the Political Authority of Speech in Hobbes, Locke, and Mill

Constellations, EarlyView.
Thomas Henry Owings
wiley   +1 more source

Chapter 1. Antipsychotic and Anti-anxiety Agents

, 1966
Publisher Summary This chapter discusses various antipsychotic and anti-anxiety agents. Most of the compounds discussed in the chapter are tested by two general methods: (1) the study of animal behavior following drug treatment in experimental models designed to mimic a clinical situation (conflict, avoidance, etc.) and (2) the measurement of ...
Scott J. Childress
semanticscholar   +4 more sources